Heather D Turner
CIK 1403571 · Chief Executive Officer · last filed 2026-05-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$759.8K
Companies
7
Total Filings
36
Lifetime Open-Market Net
-$2.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) Delisted | Director | — | $52.95 | — | $0 | 4 | 2026-05-05 |
| AVLN | Director | — | — | — | $0 | 1 | 2026-05-01 |
| LBRX | Chief Executive Officer | — | $28.42 | — | $0 | 1 | 2025-09-12 |
| LYEL | Chief General Counsel | — | $13.50 | — | $0 | 1 | 2022-03-18 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | EVP, General Counsel & Sec. | 19,250 | $0.18 | $3.4K | $0 | 2 | 2019-02-27 |
| ATRA | Former EVP, GC & Sec. | 72,989 | $10.41 | $759.8K | -$656.3K | 8 | 2018-02-12 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | SVP, Gen. Counsel & Secretary | 22,643 | — | — | -$2.29M | 19 | 2015-02-05 |
Recent Filings · Page 3 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-09-22 | Orexigen Therapeutics, Inc. (OREX) Delisted | Mixed | — | -$841.5K | EDGAR |
| 2014-02-11 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | +3,980 | $21.3K | EDGAR |
| 2013-02-19 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-07-19 | Orexigen Therapeutics, Inc. (OREX) Delisted | Mixed | — | -$496.6K | EDGAR |
| 2012-01-26 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-07-26 | Orexigen Therapeutics, Inc. (OREX) Delisted | Mixed | — | $0 | EDGAR |
| 2011-06-14 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-03-04 | Orexigen Therapeutics, Inc. (OREX) Delisted | Mixed | — | $0 | EDGAR |
| 2011-01-20 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-09-22 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.